|
Market Closed -
Nasdaq
00:00:00 26/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 5.150 USD | -4.28% |
|
-6.36% | +71.10% |
| 09-01 | Canaccord Genuity Initiates Aclaris Therapeutics at Buy With $10 Price Target | MT |
| 08-07 | Aclaris Therapeutics Gets Fast-Track Designation for Inflammation Treatment Modzatinib | DJ |
| Market Cap | 758M 665M 628M 573M 1.07B 72.66B 1.08B 7.52B 2.91B 37.12B 2.85B 2.78B 119B | P/E 2026 * |
-7.97x | P/E 2027 * | -6.55x |
|---|---|---|---|---|---|
| Enterprise Value | 605M 531M 501M 457M 855M 57.98B 861M 6B 2.32B 29.62B 2.27B 2.22B 95.2B | EV / Sales 2026 * |
95.4x | EV / Sales 2027 * | 115x |
| Free-Float |
97.82% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ACRS | Delayed | |
CBOE
| ACRS | Real-time | |
|
Tradegate
| 8AT | Real-time | |
|
Deutsche Boerse AG
| 8AT | Delayed | |
|
Börse Stuttgart
| 8AT | Delayed | |
|
Boerse Muenchen
| 8AT | Real-time |
Last Transcript: Aclaris Therapeutics, Inc.
| 1 day | -4.28% | ||
| 1 week | -6.36% | ||
| Current month | -14.88% | ||
| 1 month | -21.19% | ||
| 3 months | +4.89% | ||
| 6 months | +43.45% | ||
| Current year | +71.10% |
| 1 week | 5.04 |  | 5.76 |
| 1 month | 4.98 | | 6.3 |
| Current year | 2.49 | | 6.6 |
| 1 year | 1.74 | | 6.6 |
| 3 years | 0.59 | | 6.98 |
| 5 years | 0.59 | | 19.97 |
| 10 years | 0.59 | | 33.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Neal Walker
CEO | Chief Executive Officer | 56 | 17/01/2024 |
Hugh Davis
PSD | President | 67 | 18/11/2024 |
Kevin Balthaser
DFI | Director of Finance/CFO | 39 | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Walker
CHM | Chairman | 56 | 01/01/2023 |
Anand Mehra
BRD | Director/Board Member | 50 | 01/09/2014 |
| Director/Board Member | 59 | 01/09/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/08/26 | Exercice | Chief Technology Officer | 85,135 | 0.0610% | ||
| 04/06/26 | Aisling Capital Management LP
| Other | Company | 0 | 0% | - |
| 01/05/26 | Exercice | Chief Technology Officer | 82,080 | 0.0681% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.28% | -6.36% | +175.40% | -21.49% | 758M | |
| -3.30% | +1.50% | +51.24% | +99.26% | 72.26B | |
| +1.25% | -3.01% | +40.12% | +77.12% | 60.24B | |
| +2.12% | +5.26% | +32.50% | +21.28% | 27.73B | |
| -3.06% | -1.81% | -13.10% | +357.06% | 25.74B | |
| -0.75% | +2.56% | +0.45% | -4.46% | 24.75B | |
| +0.40% | +0.75% | +22.91% | -9.68% | 20.74B | |
| -1.70% | -2.12% | +146.86% | +314.52% | 15.06B | |
| +0.36% | -0.34% | +50.32% | +166.42% | 14.42B | |
| +0.21% | +1.17% | -8.07% | +499.10% | 14.23B | |
| Average | -0.87% | -0.24% | +49.86% | +149.91% | 27.59B | |
| Weighted average by Cap. | -0.78% | +0.29% | +36.70% | +128.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.34M 5.56M 5.25M 4.79M 8.96M 607M 9.03M 62.86M 24.35M 310M 23.8M 23.28M 997M | 5.34M 4.68M 4.42M 4.03M 7.55M 512M 7.6M 52.94M 20.5M 261M 20.04M 19.61M 840M |
| Net income | -90.33M -79.26M -74.86M -68.22M -128M -8.66B -129M -896M -347M -4.42B -339M -332M -14.21B | -112M -98.58M -93.1M -84.84M -159M -10.77B -160M -1.11B -432M -5.5B -422M -413M -17.68B |
| Net Debt | -153M -134M -127M -116M -216M -14.67B -218M -1.52B -588M -7.5B -575M -562M -24.09B | -147M -129M -121M -111M -207M -14.05B -209M -1.45B -563M -7.18B -550M -538M -23.06B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/09/26 | $5.150 | -4.28% | 1,474,099 |
| 24/09/26 | $5.380 | +2.28% | 2,488,961 |
| 23/09/26 | $5.260 | -8.04% | 1,962,832 |
| 22/09/26 | $5.720 | +2.69% | 2,879,401 |
| 21/09/26 | $5.570 | +1.27% | 1,521,430 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACRS Stock
Select your edition
All financial news and data tailored to specific country editions
